Wen-Bin Ho

USPTO Granted Patents = 20 (Patent Applications = 2)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 4.0

ph-index = 10

Forward Citations = 315(Granted Patents)

Company Filing History:

Years Active: 1998-2022

Loading Chart...

20 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11229637 - Nitrogen-containing heteroaryl compounds and methods of use thereof (2022-01-25),

2. 10646482 - Nitrogen-containing heteroaryl compounds and methods of use thereof (2020-05-12),

3. 10092558 - Nitrogen-containing heteroaryl compounds and methods of use thereof (2018-10-09),

4. 9409892 - 4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors (2016-08-09),

5. 9339527 - Nitrogen-containing heteroaryl compounds and methods of use thereof (2016-05-17),

6. 9174976 - Cyanoisoquinoline compounds and methods of use thereof (2015-11-03),

7. 9149476 - Thiochromene derivatives as HIF hydroxylase inhibitors (2015-10-06),

8. 8927591 - Thiochromene derivatives as HIF hydroxylase inhibitors (2015-01-06),

9. 8916585 - Nitrogen-containing heteroaryl compounds and methods of use thereof (2014-12-23),

10. 8765956 - Nitrogen-containing heteroaryl compounds and methods of use thereof (2014-07-01),

11. 8759373 - Cyanoisoquinoline compounds and methods of use thereof (2014-06-24),

12. 8278325 - Nitrogen-containing heteroaryl compounds and methods of use thereof (2012-10-02),

13. 8217043 - Compounds and methods for their use (2012-07-10),

14. 7928120 - Cyanoisoquinoline compounds and methods of use thereof (2011-04-19),

15. 7863292 - Nitrogen-containing heteroaryl compounds and methods of use thereof (2011-01-04),

Title: Innovations and Contributions of Wen-Bin Ho in the Field of Chemistry

Introduction

Wen-Bin Ho, based in Los Altos, California, is a distinguished inventor with a remarkable portfolio of 20 patents. His work primarily revolves around the development of innovative compounds that hold significant promise for medical applications, particularly in the treatment of conditions associated with erythropoietin.

Latest Patents

Among his most recent inventions are two notable patents involving nitrogen-containing heteroaryl compounds. These compounds are specifically designed to mediate hypoxia-inducible factors, thereby enhancing the production of endogenous erythropoietin both in vitro and in vivo. The implications of these compounds could revolutionize treatments for various erythropoietin-associated conditions, showcasing Wen-Bin’s critical role in advancing pharmaceutical chemistry.

Career Highlights

Wen-Bin Ho has made significant advancements during his career, particularly through his associations with reputable institutions like Fibrogen, Inc. and Yale University. At Fibrogen, he contributed to pioneering research that aims to improve therapeutic strategies for patients facing challenges related to anemia and oxygen deficiency.

Collaborations

Throughout his career, Wen-Bin has collaborated with a talented pool of professionals, including notable colleagues such as Lee Allen Flippin and Eric Douglas Turtle. These partnerships have fostered an environment of innovation and breakthrough discoveries in the field of medicinal chemistry.

Conclusion

Wen-Bin Ho exemplifies the impact that dedicated inventors can make in the realm of science and medicine. With his extensive patent portfolio and collaborative efforts, he continues to pave the way for novel treatments that can address critical health issues, thereby enhancing the quality of life for many individuals.

This text is generated by artificial intelligence and may not be accurate.